These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension. Ceral J, Solar M. Blood Press; 2009; 18(1-2):74-7. PubMed ID: 19353415 [Abstract] [Full Text] [Related]
5. Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial. Chapman N, Chang CL, Dahlöf B, Sever PS, Wedel H, Poulter NR, ASCOT Investigators. Circulation; 2008 Jul 01; 118(1):42-8. PubMed ID: 18559700 [Abstract] [Full Text] [Related]
12. Doxazosin: a new approach to hypertension and benign prostatic hyperplasia. Pool JL. Br J Clin Pract; 1996 Jul 01; 50(3):154-63. PubMed ID: 8733335 [Abstract] [Full Text] [Related]
13. Effect of vardenafil on blood pressure profile of patients with erectile dysfunction concomitantly treated with doxazosin gastrointestinal therapeutic system for benign prostatic hyperplasia. Ng CF, Wong A, Cheng CW, Chan ES, Wong HM, Hou SM. J Urol; 2008 Sep 01; 180(3):1042-6. PubMed ID: 18639296 [Abstract] [Full Text] [Related]
17. Add-on therapy with a nighttime dose of doxazosin in patients with uncontrolled hypertension: effects on autonomic modulation of the cardiovascular system. Guzik P, Wykretowicz A, Krauze T, Piskorski J, Adamska K, Milewska A, Wesseling KH, Wysocki H. Hypertens Res; 2008 Mar 01; 31(3):443-53. PubMed ID: 18497463 [Abstract] [Full Text] [Related]